These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33832398)

  • 1. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Levi M; Iba T
    Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Dysfunction.
    Fei Y; Tang N; Liu H; Cao W
    Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
    Bhattacharjee S; Banerjee M; Pal R
    Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism.
    Ahmad F; Kannan M; Ansari AW
    Cytokine Growth Factor Rev; 2022 Feb; 63():58-68. PubMed ID: 34750061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
    Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
    J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19, coagulopathy and venous thromboembolism: more questions than answers.
    Marietta M; Coluccio V; Luppi M
    Intern Emerg Med; 2020 Nov; 15(8):1375-1387. PubMed ID: 32653981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy.
    Mitchell WB; Davila J; Keenan J; Jackson J; Tal A; Morrone KA; Silver EJ; O'Brien S; Manwani D
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28975. PubMed ID: 33661561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
    Shi C; Wang C; Wang H; Yang C; Cai F; Zeng F; Cheng F; Liu Y; Zhou T; Deng B; Vlodavsky I; Li JP; Zhang Y
    Clin Transl Sci; 2020 Nov; 13(6):1087-1095. PubMed ID: 32881340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peculiarities of blood coagulation disorders in patients with COVID-19].
    Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
    Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection.
    AlNafea HM; Korish AA
    Blood Coagul Fibrinolysis; 2023 Apr; 34(3):129-137. PubMed ID: 36966750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
    Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-induced coagulopathy: Experience, achievements, prospects.
    Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
    Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC
    Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.